S 204 · 115th Congress 2017–2019, ended

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

Introduced Jan 24, 2017 Originated Senate Became Public Law 115-176 Sponsor Ron Johnson R-WI

Fact sheet Spreadsheet

Latest action · May 30, 2018 Became Public Law No: 115-176.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedJan 24, 2017
  2. Passed SenateAug 3, 2017
  3. Passed HouseMay 22, 2018
  4. To the PresidentMay 24, 2018
  5. Became lawMay 30, 2018Public Law 115-176

Summary

Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to exempt, from specified requirements and restrictions under that Act and other laws, the provision of certain unapproved, investigational drugs to a terminally ill patient who has exhausted approved treatment options and is unable to participate in a clinical trial involving the drugs. The manufacturer or sponsor of an eligible investigational drug must report annually to the Food and Drug Administration (FDA) on any use of the drug in accordance with these provisions. The FDA shall post an annual summary report of such use on its website.

The bill limits the liability of a sponsor, manufacturer, prescriber, or dispenser that provides, or declines to provide, an eligible investigational drug to an eligible patient in accordance with the bill.

    Recorded votes 2

    Newest first. Open one to see how every member voted.

    Roll callQuestionResultDate
    House 214Passed250–169May 22, 2018
    House 213Failed187–231May 22, 2018

    Cosponsors 46

    Members who signed on, in the order they did. Signatures ran from Jan 24, 2017 to Mar 29, 2017; 43 are original cosponsors, there from the day it was introduced.

    SeatCosponsorSigned on
    I-MEAngus S. King Jr.OriginalJan 24, 2017
    R-NEBen SasseOriginalJan 24, 2017
    R-TNBob CorkerOriginalJan 24, 2017
    R-IAChuck GrassleyOriginalJan 24, 2017
    R-COCory GardnerOriginalJan 24, 2017
    R-AKDan SullivanOriginalJan 24, 2017
    R-GADavid PerdueOriginalJan 24, 2017
    R-NVDean HellerOriginalJan 24, 2017
    R-NEDeb FischerOriginalJan 24, 2017
    R-IDJames E. RischOriginalJan 24, 2017
    R-OKJames LankfordOriginalJan 24, 2017
    R-OKJames M. InhofeOriginalJan 24, 2017
    R-AZJeff FlakeOriginalJan 24, 2017
    R-KSJerry MoranOriginalJan 24, 2017
    D-INJoe DonnellyOriginalJan 24, 2017
    Show all 46 cosponsors

    Committees 2

    Where it was sent and what each committee and subcommittee did with it, in order.

    ChamberCommitteeWhat it did
    SenateHealth, Education, Labor, and Pensions Committee
    Referred Jan 24, 2017Discharged Aug 3, 2017
    HouseEnergy and Commerce Committee
    Referred Aug 4, 2017
    Health Subcommittee
    Referred Aug 11, 2017

    Actions 23

    Everything that happened, newest first.

    1. May 30, 2018Signed by President.
    2. May 30, 2018Became Public Law No: 115-176.
    3. May 24, 2018Presented to President.
    4. May 22, 2018Considered under the provisions of rule H. Res. 905. (consideration: CR H4355-4366)
    5. May 22, 2018Rule provides for consideration of H.R. 5515, S. 204 and S. 2155. The resolution provides for one hour of general debate on H.R. 5515, S. 204 and S. 2155. The resolution provides for consideration of S. 2155 and S. 204 under a closed rule. Also, the resolution provides for consideration of H.R. 5515 under a structured rule and makes an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115-70 considered as adopted.
    Show all 23 actions

    In the Congressional Record 7

    Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

    WhereIn the RecordMembersDate
    ExtensionsDebate and remarks E751Anna G. Eshoo D-CAMay 29, 2018
    HouseDebate and remarks H4682Doug LaMalfa R-CAMay 23, 2018
    HouseDebate and remarks H4292–H4301, H4355–H4366Text printed H4292, H4355Amendments H4300Motions H4363Recorded votes H4300, H4301, H4365consideration (H. Res. 905), previous questionSchakowsky motion to recommit (improve FDA expanded access program to allow patients access to experimental life-saving drugs)Alcee L. Hastings D-FL (amendment), Andy Biggs R-AZ, Brian K. Fitzpatrick R-PA, Doris O. Matsui D-CA, Earl L. "Buddy" Carter R-GA, Frank Pallone, Jr. D-NJ, Greg Walden R-OR, Janice D. Schakowsky D-IL (motion), Jerry McNerney D-CA, Joe Barton R-TX, Kathy Castor D-FL, Michael C. Burgess R-TX, Paul Tonko D-NYMay 22, 2018
    HouseDeclaratory Statements H4285—May 21, 2018
    HouseDebate and remarks H485Mo Brooks R-ALJan 18, 2018
    Show all 7 days

    Research

    What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.

    Printed hearings 1

    Hearings whose printed record names this bill, newest first: hearings on it, and wider hearings where it came up.

    NumberHearingCommitteeHeld
    Serial No. 115-60EXAMINING PATIENT ACCESS TO INVESTIGATIONAL DRUGS239 pagesEnergy and Commerce CommitteeOct 3, 2017

    CRS reports 5

    Congressional Research Service work that CRS links to this bill or the law it became, newest first.

    Cite it 5

    Products on other subjects that cite it, usually among other measures.

    Amendments 1

    Amendments offered to this bill.

    AmendmentDescriptionOffered byStatus
    SA 753In the nature of a substitute.Ron Johnson R-WIAmendment SA 753 agreed to in Senate by Unanimous Consent.

    Related bills 4

    Companion bills and other measures the record links to this one.

    BillTitleRelationshipLatest action
    HR 878Right to Try Act of 2017Related billMar 2, 2017
    HRES 905Providing for consideration of the bill (H.R. 5515) to authorize appropriations for fiscal year 2019 for military activities of the Department of Defense and for military construction, to prescribe military personnel strengths for such fiscal year, and for other purposes; providing for consideration of the bill (S. 204) to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes; and providing for consideration of the bill (S. 2155) to promote economic growth, provide tailored regulatory relief, and enhance consumer protections, and for other purposes.Related billMay 22, 2018
    HR 2368Right to Try ActRelated billJun 7, 2017
    HR 5247Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2018Related billApr 9, 2018

    Titles 7

    Every title it has carried, official and short, at each stage.

    Official Title
    An act to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes
    Short Title
    Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
    Official Title as Introduced
    A bill to authorize the use of unapproved medical products by patients diagnosed with a terminal illness in accordance with State law, and for other purposes.
    Short Titles as Introduced
    Trickett Wendler Right to Try Act of 2017
    Short Titles as Passed House
    Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
    Short Titles as Passed Senate
    Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017
    Short Titles as Enacted
    Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

    Subjects

    Assigned by the Library of Congress. Policy area: Health.

    Text 4

    Each version as it was printed, newest first.

    1. —Enrolled Bill
    2. Aug 4, 2017Referred in House
    3. Aug 3, 2017Engrossed in Senate
    4. Jan 24, 2017Introduced in Senate

    Support LegiList

    This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

    $1 $5 $10

    Processed by Stripe in a separate window. LegiList never sees card details.

    Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.